Day One Biopharmaceuticals (DAWN) December 10 and 11 calls active
Tweet
Share
E-mailGet Alerts DAWN Hot Sheet
Join SI Premium – FREE
Day One Biopharmaceuticals (NASDAQ: DAWN) 30-day call option implied volatility is at 141; compared to its 52-week range of 44 to 178 with a focus on December 10 and 11 calls as share price up 8.2%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ferguson Enterprises to Join S&P 500; ADI Global Distribution to Join S&P SmallCap 600
- ITC Ltd. (ITC:IN) PT Lowered to INR310 at JPMorgan
- HSBC Reiterates Buy Rating on Gail (India) Ltd. (GAIL:IN) (GAILF)
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
